6-[8-[[1-(2-hydroxyethyl)pyrazol-4-yl]amino]imidazo[1,2-a]pyrazin-6-yl]-4H-pyrano[2,3-b]pyridin-3-one
C19H17N7O3 — CID 158533061
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[8-[[1-(2-hydroxyethyl)pyrazol-4-yl]amino]imidazo[1,2-a]pyrazin-6-yl]-4H-pyrano[2,3-b]pyridin-3-one
6-[8-[[1-(2-hydroxyethyl)pyrazol-4-yl]amino]imidazo[1,2-a]pyrazin-6-yl]-4H-pyrano[2,3-b]pyridin-3-one (PubChem CID 158533061) has the molecular formula C19H17N7O3 and a molecular weight of 391.39 g/mol. Its IUPAC name is 6-[8-[[1-(2-hydroxyethyl)pyrazol-4-yl]amino]imidazo[1,2-a]pyrazin-6-yl]-4H-pyrano[2,3-b]pyridin-3-one.
Molecular Properties
| Compound Name | 6-[8-[[1-(2-hydroxyethyl)pyrazol-4-yl]amino]imidazo[1,2-a]pyrazin-6-yl]-4H-pyrano[2,3-b]pyridin-3-one |
|---|---|
| PubChem CID | 158533061 |
| Molecular Formula | C19H17N7O3 |
| Molecular Weight | 391.39 g/mol |
| Exact Mass | 391.14 |
| IUPAC Name | 6-[8-[[1-(2-hydroxyethyl)pyrazol-4-yl]amino]imidazo[1,2-a]pyrazin-6-yl]-4H-pyrano[2,3-b]pyridin-3-one |
| SMILES | O=C1COc2ncc(-c3cn4ccnc4c(Nc4cnn(CCO)c4)n3)cc2C1 |
| InChI | InChI=1S/C19H17N7O3/c27-4-3-26-9-14(8-22-26)23-17-18-20-1-2-25(18)10-16(24-17)13-5-12-6-15(28)11-29-19(12)21-7-13/h1-2,5,7-10,27H,3-4,6,11H2,(H,23,24) |
| InChIKey | HNPNVHYNDDETAU-UHFFFAOYSA-N |
| XLogP | 1.23 |
| TPSA | 119.46 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 391.39 |
| LogP ≤ 5 | 1.23 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158533061 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.